tiprankstipranks
Dianthus Therapeutics (DNTH)
NASDAQ:DNTH

Dianthus Therapeutics (DNTH) Similar Stocks

Compare
310 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Dianthus Therapeutics
$23.67
$701.45M
-1.25%
3 Buy
0 Hold
0 Sell
Strong Buy
Alnylam Pharma
$250.59
$32.49B
61.94%
15 Buy
3 Hold
0 Sell
Strong Buy
Amgen
$303.01
$160.05B
39.41
7.98%
11 Buy
7 Hold
1 Sell
Moderate Buy
Biogen
$140.64
$20.59B
12.58
-37.02%
12 Buy
13 Hold
0 Sell
Moderate Buy
Repligen
$158.99
$9.11B
-18.09%
9 Buy
1 Hold
0 Sell
Strong Buy
Vertex Pharmaceuticals
$484.24
$123.34B
13.46%
14 Buy
12 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
DNTH
Dianthus Therapeutics
23.67
-0.77
-3.15%
ALNY
Alnylam Pharma
250.59
92.94
58.95%
AMGN
Amgen
303.01
22.39
7.98%
BIIB
Biogen
140.64
-82.68
-37.02%
RGEN
Repligen
158.99
-37.53
-19.10%
VRTX
Vertex Pharmaceuticals
484.24
54.13
12.59%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis